Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis

19Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

We report a patient with rheumatoid arthritis (RA) who developed leukoencephalopathy while being treated with low-dose methotrexate (MTX). She suddenly developed loss of recent memory and left homonymous hemianopsia ascribable to the bilateral but right-predominant occipitotemporal lesions. Intravenous administration of dexamethasone and cessation of MTX quickly relieved her clinical symptoms. Low-dose MTXinduced leukoencephalopathy is a rare complication in RA, but is important with regard to the possibility of serious neurological sequellae. © 2011 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Matsuda, M., Kishida, D., Kinoshita, T., Hineno, A., Shimojima, Y., Fukushima, K., & Ikeda, S. I. (2011). Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis. Internal Medicine, 50(19), 2219–2222. https://doi.org/10.2169/internalmedicine.50.5552

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free